TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16641607

Group type: EXPERIMENTAL
Intervention: Calcitonin + Resistance Exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Calcitonin
Number of subjects: 18
Study: 14640385

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 101
Study: 10992845

Group type: EXPERIMENTAL
Intervention: 1 litre of crystalloid preload (Group 1)
Number of subjects: 95

Group type: COMPARATOR
Intervention: No preload (Group 2)
Number of subjects: 95
Study: 8774216

Group type: EXPERIMENTAL
Intervention: Dietary fibre extracted from pea hulls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary fibre extracted from carrots
Number of subjects: 0

Group type: COMPARATOR
Intervention: Habitual diet (control)
Number of subjects: 0
Study: 1476763

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 6378895

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 66
Study: 31449880

Group type: EXPERIMENTAL
Intervention: TX Sprouts intervention (gardening, nutrition, and cooking activities)
Number of subjects: 3137

Group type: COMPARATOR
Intervention: Delayed intervention (same protocol as intervention arm)
Number of subjects: 3137
Study: 29330461

Group type: EXPERIMENTAL
Intervention: C4 dietary oil (10.7 g) plus 200 g carrot
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Olive oil (19 g) plus 200 g carrot
Number of subjects: 13

Group type: COMPARATOR
Intervention: Carrot (200 g)
Number of subjects: 13
Study: 27856377

Group type: EXPERIMENTAL
Intervention: Erbium-YAG laser
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no laser)
Number of subjects: 24
Study: 25036538

Group type: EXPERIMENTAL
Intervention: Living Through Distress (LTD) programme, a DBT-informed skills group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Living Through Distress (LTD) programme
Number of subjects: 82
Study: 22932281

Group type: EXPERIMENTAL
Intervention: EPA and DHA supplementation (1, 2, or 4 times/week)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: EPA and DHA supplementation
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Plasma phosphatidylcholine EPA plus DHA
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Platelet and mononuclear cell EPA plus DHA
Number of subjects: 204
Study: 20953791

Group type: EXPERIMENTAL
Intervention: GA 20 mg/0.5 mL (reduced volume formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GA 20 mg/1.0 mL (marketed formulation)
Number of subjects: 0
Study: 16947012

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFS) with three doses of mesna
Number of subjects: 33
Study: 14965885

Group type: EXPERIMENTAL
Intervention: Safer Bars intervention
Number of subjects: 734

Group type: COMPARATOR
Intervention: Control bars
Number of subjects: 734
Study: 11503471

Group type: EXPERIMENTAL
Intervention: Compression stockings (compression class 2, 25‐35 mmHg at the ankle)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Compression stockings (compression class 2)
Number of subjects: 22
Study: 9512251

Group type: EXPERIMENTAL
Intervention: Co-culture with assisted hatching
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no co-culture)
Number of subjects: 200

Group type: COMPARATOR
Intervention: ICSI or ICSI/IVF
Number of subjects: 200
Study: 7848788

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combination therapy (Diltiazem 120 mg + Enalapril 10 mg)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Diltiazem
Number of subjects: 147

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 147
Study: 3057139

Group type: EXPERIMENTAL
Intervention: Antenatal steroids (20 mg dexamethasone)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 335
Study: 30826266

Group type: EXPERIMENTAL
Intervention: Chronic stimulation (CHR)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Experimental stimulation (EXP)
Number of subjects: 12
Study: 29703087

Group type: EXPERIMENTAL
Intervention: Laser navigation system
Number of subjects: 75

Group type: COMPARATOR
Intervention: Conventional fluoroscopic imaging
Number of subjects: 75
Study: 27135465

Group type: COMPARATOR
Intervention: Lidocaine injection
Number of subjects: 28

Group type: COMPARATOR
Intervention: Radiofrequency treatment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 28
Study: 24479702

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) carried out by a GP
Number of subjects: 750

Group type: COMPARATOR
Intervention: Routine medical care (Control)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 750
Study: 22296076

Group type: EXPERIMENTAL
Intervention: 5 mg ulipristal acetate
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: 10 mg ulipristal acetate
Number of subjects: 307

Group type: COMPARATOR
Intervention: leuprolide acetate
Number of subjects: 307
Study: 20659392

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHA-P)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 149
Study: 17208307

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.15 mg/kg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Dexamethasone 0.6 mg/kg
Number of subjects: 41
Study: 16157934

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 3612

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3612
Study: 12450895

Group type: EXPERIMENTAL
Intervention: Men born short (≤ 50.5 cm) who became tall adults (175‐180.5 cm)
Number of subjects: 4775

Group type: EXPERIMENTAL
Intervention: Men born short (≤ 50.5 cm) who became tall adults (> 180.5 cm)
Number of subjects: 4775

Group type: COMPARATOR
Intervention: Birth length
Number of subjects: 4775

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 4775
Study: 10095921

Group type: EXPERIMENTAL
Intervention: Acipole (Lactobacillus acidophilus + Kefir greins)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine antibiotics
Number of subjects: 120
Study: 7759449

Group type: EXPERIMENTAL
Intervention: Local anesthetic (0.5% bupivacaine hydrochloride) injected into the base of the fourth finger
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saline injected into the base of the index finger
Number of subjects: 5
Study: 2275322

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 377448

Group type: EXPERIMENTAL
Intervention: Ketoprofen (200 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 55
Study: 31800551

Group type: EXPERIMENTAL
Intervention: Surgical decompression
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mega dose corticosteroid (30 mg/kg stat and 15 mg/kg every 6 hours for 3 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 30973544

Group type: EXPERIMENTAL
Intervention: Immediate ART (initiated at a median of 6 days)
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Deferred ART (initiated at a median of 699 days)
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Immediate ART
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Spontaneous virologic suppression
Number of subjects: 1134
Study: 28470106

Group type: EXPERIMENTAL
Intervention: NEUROD2 polymorphism rs11078918
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: NEUROD2 polymorphism rs12453682
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Change in neuropsychological test results during antipsychotic treatment
Number of subjects: 167
Study: 26152326

Group type: EXPERIMENTAL
Intervention: Minimal home-based psychoeducative intervention (single session + telephone booster)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study: 24850465

Group type: EXPERIMENTAL
Intervention: Fish-based diet (n-3 PUFAs ≧ 3.0 g/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 23
Study: 22702523

Group type: EXPERIMENTAL
Intervention: Oral fidaxomicin for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral vancomycin
Number of subjects: 0
Study: 20034916

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with docetaxel combined with pirarubicin (TThp)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with docetaxel combined with epirubicin (TE)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (both regimens)
Number of subjects: 120
Study: 17869373

Group type: EXPERIMENTAL
Intervention: Psychometric test battery
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Portosystemic-Encephalopathy-Syndrome (PSE) test
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Psychometric-Hepatic-Encephalopathy-Sum (PHES)-score
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Number-connection-tests-A
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Number-connection-tests-B
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Line-tracing-test
Number of subjects: 217
Study: 15076172

Group type: EXPERIMENTAL
Intervention: Captopril treatment
Number of subjects: 10985

Group type: EXPERIMENTAL
Intervention: Captopril therapy
Number of subjects: 10985

Group type: COMPARATOR
Intervention: Conventional diuretic and/or beta-blocker therapy
Number of subjects: 10985
Study: 12034161

Group type: EXPERIMENTAL
Intervention: Multidisciplinary, home-based intervention (HBI)
Number of subjects: 90
Study: 10360293

Group type: EXPERIMENTAL
Intervention: Propranolol, 40 mg, administered 1 hour prior to surgery
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 7731628

Group type: EXPERIMENTAL
Intervention: New therapeutic options for conservative treatment of vulvar lichen sclerosus
Number of subjects: 0
Study: 2654435

Group type: EXPERIMENTAL
Intervention: 16-week aerobic exercise program at 70% of maximal heart rate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 466329

Group type: EXPERIMENTAL
Intervention: Conventional treatment from qualified speech therapists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment from non‐professional volunteers
Number of subjects: 0
Study: 31829912

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before RT
Number of subjects: 432

Group type: COMPARATOR
Intervention: Concurrent ADT for 6 months starting simultaneously with RT
Number of subjects: 432
Study: 31136069

Group type: EXPERIMENTAL
Intervention: Low-pressure (LP; 8 mmHg)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Standard pressure (SP; 15 mmHg, control)
Number of subjects: 178
Study: 28938962

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 2281

Group type: EXPERIMENTAL
Intervention: Combination of oral anticoagulants and antiplatelet drugs
Number of subjects: 2281
Study: 25962329

Group type: EXPERIMENTAL
Intervention: Whole-body cooling (intermittent immersion in 14°C water until rectal temperature reached 35.5°C or for a maximum of 170 min)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Whole-body cooling
Number of subjects: 32
Study: 23412808

Group type: EXPERIMENTAL
Intervention: Herbal/pharmaceutical supplements
Number of subjects: 132

Group type: COMPARATOR
Intervention: Referents (age-matched female subjects, n=128)
Number of subjects: 132
Study: 16778330

Group type: EXPERIMENTAL
Intervention: New DeltaBP-estimation device (BP-ECG monitor)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: BP-ECG monitoring device
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Portable device (TM2425)
Number of subjects: 293
Study: 15357561

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (MgSO4)
Number of subjects: 12
Study: 11053725

Group type: EXPERIMENTAL
Intervention: Patients with hypertrophic cardiomyopathy (HC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with idiopathic dilated cardiomyopathy (IDC)
Number of subjects: 0
Study: 8780630

Group type: EXPERIMENTAL
Intervention: CT-RT group (cisplatin and vinblastine followed by radiation therapy)
Number of subjects: 155

Group type: COMPARATOR
Intervention: RT group (radiation therapy alone)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: CT-RT group
Number of subjects: 155

Group type: COMPARATOR
Intervention: RT group
Number of subjects: 155
Study: 1595797

Group type: EXPERIMENTAL
Intervention: Mefenamic acid (500 mg, three times daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 3938014

Group type: EXPERIMENTAL
Intervention: RMSF cases (n=16)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Controls (n=10)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: RMSF cases (n=8, identified by direct fluorescent antibody technique)
Number of subjects: 26
Study: 31607547

Group type: EXPERIMENTAL
Intervention: ONS
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ONS + RE
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ONS + AE
Number of subjects: 45
Study: 31628016

Group type: EXPERIMENTAL
Intervention: Tumour Treating Fields (TTFields) at a frequency of 150 kHz delivered to the thorax in combination with intravenous pemetrexed (500 mg/m2 on day 1) and either cisplatin (75 mg/m2 on day 1) or carboplatin (AUC 5 on day 1) every 21 days for up to six cycles.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tumour Treating Fields (TTFields) as maintenance treatment after chemotherapy.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Chemotherapy (pemetrexed and platinum) without TTFields.
Number of subjects: 80
Study: 28407637

Group type: EXPERIMENTAL
Intervention: Pneumatic Compression
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cycling Exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 26114588

Group type: EXPERIMENTAL
Intervention: Oxybutynin (2.5 mg per day, increased to 7.5 mg per day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 62
Study: 24135239

Group type: EXPERIMENTAL
Intervention: Lobe-specific mediastinal lymphadenectomy (LL)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Systematic mediastinal lymphadenectomy (SL)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Comparison of LL and SL
Number of subjects: 96
Study: 21294116

Group type: EXPERIMENTAL
Intervention: Building Spiritual Strength (BSS) intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 54
Study: 19826471

Group type: EXPERIMENTAL
Intervention: Observation of regretful outcomes in another individual
Number of subjects: 0

Group type: COMPARATOR
Intervention: First-person experience of regret
Number of subjects: 0
Study: 16845694

Group type: EXPERIMENTAL
Intervention: wIRA irradiation
Number of subjects: 111
Study: 14678128

Group type: EXPERIMENTAL
Intervention: VVI pacing (80 beats/min)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: VVIR pacing (minimum rate 80 beats/min)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: DDI pacing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Rate responsive mode (RR-ON)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Rate responsive mode (RR-OFF)
Number of subjects: 28
Study: 11177415

Group type: EXPERIMENTAL
Intervention: True memories
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: False memories
Number of subjects: 0

Group type: COMPARATOR
Intervention: Left hemifield presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frontal slow wave activity
Number of subjects: 0
Study: 9375535

Group type: EXPERIMENTAL
Intervention: Two-handled (levered) shovel
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional shovel
Number of subjects: 10
Study: 1587408

Group type: EXPERIMENTAL
Intervention: Intravenous cerulein at doses of 30-60 ng/kg.h
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 mg/kg.h loxiglumide with cerulein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1000-kcal solid/liquid meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5 mg/kg.h loxiglumide with a meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Loxiglumide alone
Number of subjects: 16
Study: 3884409

Group type: EXPERIMENTAL
Intervention: Piretanide tablet
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Slow-release piretanide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 40
Study: 31439069

Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game
Number of subjects: 204
Study: 30055710

Group type: EXPERIMENTAL
Intervention: Out‐of‐School Nutrition and Physical Activity intervention
Number of subjects: 400
Study: 26802004

Group type: EXPERIMENTAL
Intervention: SCFI: STD‐related cognitive plus fear appeal imagery approach
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: SC: STD‐related cognitive approach
Number of subjects: 396

Group type: COMPARATOR
Intervention: Control: HIV‐related information based approach
Number of subjects: 396
Study: 25074984

Group type: EXPERIMENTAL
Intervention: Testosterone-enanthate (TE) 125 mg/wk
Number of subjects: 60

Group type: COMPARATOR
Intervention: Finasteride (5 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 23095425

Group type: EXPERIMENTAL
Intervention: Oral methylphenidate stimulant medication
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Completion of a more difficult PERMP
Number of subjects: 7
Study: 20124887

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (targeting normoglycemia, between 4.4 and 6.1 mmol/L)
Number of subjects: 2748

Group type: COMPARATOR
Intervention: Conventional insulin therapy (infusing insulin when blood glucose levels were >12 mmol/L and stopping at 10 mmol/L)
Number of subjects: 2748
Study: 17393164

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel at a dose of 100 mg/m2 followed by carboplatin AUC 2, administered in blocks of six cycles with treatment-free intervals.
Number of subjects: 129
Study: 16096324

Group type: EXPERIMENTAL
Intervention: Salpingectomy prior to IVF
Number of subjects: 95

Group type: COMPARATOR
Intervention: Optional salpingectomy after a failed cycle
Number of subjects: 95
Study: 12469706

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) plus bisphosphonate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HRT plus selective estrogen receptor modulator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HRT plus PTH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HRT alone or in combination with bisphosphonate or PTH
Number of subjects: 0
Study: 10603129

Group type: EXPERIMENTAL
Intervention: Prolonged prednisolone treatment (16 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard prednisolone treatment (8 weeks)
Number of subjects: 45
Study: 8943890

Group type: EXPERIMENTAL
Intervention: Splenic irradiation
Number of subjects: 229

Group type: COMPARATOR
Intervention: No splenic irradiation
Number of subjects: 229
Study: 1770568

Group type: EXPERIMENTAL
Intervention: Continuous intravenous pethidine infusion (100 mg.24 h‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous epidural pethidine infusion (100 mg.24 h‐1)
Number of subjects: 20
Study: 6812407

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 29176388

Group type: EXPERIMENTAL
Intervention: Citrulline Malate (8 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no drink mixture)
Number of subjects: 12
Study: 28718101

Group type: EXPERIMENTAL
Intervention: AuraGain laryngeal mask
Number of subjects: 88

Group type: COMPARATOR
Intervention: Slit Guedel tube
Number of subjects: 88
Study: 25825944

Group type: EXPERIMENTAL
Intervention: Continual uFSH (75 U, 3 times a week) and hCG (2000 U, twice a week)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sequential uFSH (75 U, 3 times a week every other 3 months) and hCG (2000 U, twice a week)
Number of subjects: 67
Study: 24393576

Group type: EXPERIMENTAL
Intervention: Catheter ablation with documented pulmonary vein isolation
Number of subjects: 82

Group type: COMPARATOR
Intervention: Catheter ablation without antiarrhythmic drug therapy
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Electrophysiologically successful ablation
Number of subjects: 82
Study: 21236648

Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion (ATD) diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control, balanced diet
Number of subjects: 11
Study: 19265599

Group type: EXPERIMENTAL
Intervention: Recommended drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs only to be used in special circumstances
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drugs which should not be used in normal circumstances
Number of subjects: 0
Study: 17701882

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.4 mg daily for 12 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 15185523

Group type: EXPERIMENTAL
Intervention: Urostim and antibiotic
Number of subjects: 46

Group type: COMPARATOR
Intervention: Antibiotic only
Number of subjects: 46
Study: 11817871

Group type: EXPERIMENTAL
Intervention: Cemex Rx
Number of subjects: 47

Group type: COMPARATOR
Intervention: Palacos R
Number of subjects: 47
Study: 9563668

Group type: EXPERIMENTAL
Intervention: Prophylactic penicillin
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Beta-lactamase stable antibiotic
Number of subjects: 102